INO
Price
$1.90
Change
+$0.01 (+0.53%)
Updated
Apr 29, 04:55 PM (EDT)
Capitalization
69.31M
PCSA
Price
$0.23
Change
-$0.01 (-4.17%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
1.24M
Ad is loading...

INO vs PCSA

Header iconINO vs PCSA Comparison
Open Charts INO vs PCSABanner chart's image
Inovio Pharmaceuticals
Price$1.90
Change+$0.01 (+0.53%)
Volume$100
Capitalization69.31M
Processa Pharmaceuticals
Price$0.23
Change-$0.01 (-4.17%)
Volume$1.7K
Capitalization1.24M
INO vs PCSA Comparison Chart
Loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INO vs. PCSA commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INO is a StrongBuy and PCSA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (INO: $1.89 vs. PCSA: $0.24)
Brand notoriety: INO: Notable vs. PCSA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INO: 56% vs. PCSA: 9%
Market capitalization -- INO: $69.31M vs. PCSA: $1.24M
INO [@Biotechnology] is valued at $69.31M. PCSA’s [@Biotechnology] market capitalization is $1.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green whilePCSA’s FA Score has 1 green FA rating(s).

  • INO’s FA Score: 0 green, 5 red.
  • PCSA’s FA Score: 1 green, 4 red.
According to our system of comparison, PCSA is a better buy in the long-term than INO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INO’s TA Score shows that 6 TA indicator(s) are bullish while PCSA’s TA Score has 5 bullish TA indicator(s).

  • INO’s TA Score: 6 bullish, 3 bearish.
  • PCSA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, INO is a better buy in the short-term than PCSA.

Price Growth

INO (@Biotechnology) experienced а +6.18% price change this week, while PCSA (@Biotechnology) price change was +6.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was -2.03%, and the average quarterly price growth was -10.94%.

Reported Earning Dates

INO is expected to report earnings on May 08, 2024.

PCSA is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INO($69.3M) has a higher market cap than PCSA($1.24M). INO YTD gains are higher at: 6.180 vs. PCSA (-73.376). PCSA has higher annual earnings (EBITDA): -12.05M vs. INO (-103.95M). INO has more cash in the bank: 94.1M vs. PCSA (1.19M). PCSA has less debt than INO: PCSA (73.5K) vs INO (11.9M). INO has higher revenues than PCSA: INO (218K) vs PCSA (0).
INOPCSAINO / PCSA
Capitalization69.3M1.24M5,589%
EBITDA-103.95M-12.05M863%
Gain YTD6.180-73.376-8%
P/E RatioN/AN/A-
Revenue218K0-
Total Cash94.1M1.19M7,901%
Total Debt11.9M73.5K16,190%
FUNDAMENTALS RATINGS
INO: Fundamental Ratings
INO
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INOPCSA
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with RPTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
+1.07%
RPTX - INO
57%
Loosely correlated
+8.80%
BCYC - INO
51%
Loosely correlated
-0.24%
CLDX - INO
43%
Loosely correlated
+9.15%
ONCO - INO
43%
Loosely correlated
+14.45%
DNLI - INO
43%
Loosely correlated
+3.64%
More

PCSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with OPORF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then OPORF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
-0.80%
OPORF - PCSA
51%
Loosely correlated
N/A
INO - PCSA
38%
Loosely correlated
+1.07%
ONCO - PCSA
34%
Loosely correlated
+14.45%
IMNN - PCSA
32%
Poorly correlated
-2.00%
HSTC - PCSA
28%
Poorly correlated
N/A
More